Ignite Creation Date:
2024-05-05 @ 11:18 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01301898
Status:
COMPLETED
Last Update Posted:
2012-02-14
First Post:
2011-02-22
Brief Title:
To Evaluate the Safety and Efficacy of GC1111 Recombinant Human Iduronate-2-sulfatase in Hunter Syndrome Patients
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Organization Data
Organization:
GC Biopharma Corp
Class:
INDUSTRY
Study ID:
GC1111_P12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Green Cross Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None